Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

PES1 promotes breast cancer by differentially regulating ERα and ERβ.

Cheng L, Li J, Han Y, Lin J, Niu C, Zhou Z, Yuan B, Huang K, Li J, Jiang K, Zhang H, Ding L, Xu X, Ye Q.

J Clin Invest. 2012 Aug;122(8):2857-70. doi: 10.1172/JCI62676. Epub 2012 Jul 23.

2.

PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer.

Li J, Zhuang Q, Lan X, Zeng G, Jiang X, Huang Z.

IUBMB Life. 2013 Dec;65(12):1017-25. doi: 10.1002/iub.1228. Epub 2013 Nov 24.

3.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

4.

Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.

Int J Oncol. 2005 Aug;27(2):327-35.

PMID:
16010412
5.

Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.

Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.

Cancer Res. 2007 Apr 15;67(8):3955-62.

6.

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.

Oncogene. 2008 Feb 7;27(7):1019-32. Epub 2007 Aug 13.

PMID:
17700529
7.

The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.

Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, Zheng Y, Ye Q.

Biochim Biophys Acta. 2008 Jun;1783(6):1220-8. doi: 10.1016/j.bbamcr.2008.01.026. Epub 2008 Feb 12.

8.
9.

Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.

Wihlén B, Ahmed S, Inzunza J, Matthews J.

Mol Cancer Res. 2009 Jun;7(6):977-86. doi: 10.1158/1541-7786.MCR-08-0396. Epub 2009 May 26.

10.

Regulation of estrogen receptors alpha and beta in human breast carcinoma by exogenous leptin in nude mouse xenograft model.

Yu W, Gu JC, Liu JZ, Wang SH, Wang Y, Zhang ZT, Ma XM, Song MM.

Chin Med J (Engl). 2010 Feb 5;123(3):337-43.

PMID:
20193256
11.

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA.

Oncogene. 2013 May 9;32(19):2390-402. doi: 10.1038/onc.2012.261. Epub 2012 Jul 2.

PMID:
22751110
12.

Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.

Lo R, Burgoon L, Macpherson L, Ahmed S, Matthews J.

Biochim Biophys Acta. 2010 May-Jun;1799(5-6):469-79. doi: 10.1016/j.bbagrm.2010.01.005. Epub 2010 Jan 14.

13.

CpG methylation of the ERalpha and ERbeta genes in breast cancer.

Kim SJ, Kim TW, Lee SY, Park SJ, Kim HS, Chung KW, Lee ES, Kang HS.

Int J Mol Med. 2004 Aug;14(2):289-93.

PMID:
15254780
14.

Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.

Treeck O, Lattrich C, Springwald A, Ortmann O.

Breast Cancer Res Treat. 2010 Apr;120(3):557-65. doi: 10.1007/s10549-009-0413-2. Epub 2009 May 12.

PMID:
19434490
15.

Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.

Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R, Luo S, Schroth GP, Benes V, Weisz A.

BMC Genomics. 2011 Jan 14;12:36. doi: 10.1186/1471-2164-12-36.

16.

Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.

Paris O, Ferraro L, Grober OM, Ravo M, De Filippo MR, Giurato G, Nassa G, Tarallo R, Cantarella C, Rizzo F, Di Benedetto A, Mottolese M, Benes V, Ambrosino C, Nola E, Weisz A.

Oncogene. 2012 Sep 20;31(38):4196-206. doi: 10.1038/onc.2011.583. Epub 2012 Jan 9.

PMID:
22231442
17.

Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.

Mafuvadze B, Liang Y, Hyder SM.

Oncol Rep. 2014 Oct;32(4):1727-33. doi: 10.3892/or.2014.3332. Epub 2014 Jul 15.

PMID:
25051231
18.

Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.

Chang EC, Frasor J, Komm B, Katzenellenbogen BS.

Endocrinology. 2006 Oct;147(10):4831-42. Epub 2006 Jun 29.

PMID:
16809442
19.

Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7.

Peekhaus NT, Chang T, Hayes EC, Wilkinson HA, Mitra SW, Schaeffer JM, Rohrer SP.

J Mol Endocrinol. 2004 Jun;32(3):987-95.

PMID:
15171727
20.

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.

Mol Endocrinol. 2006 Dec;20(12):3070-82. Epub 2006 Aug 10.

PMID:
16901971

Supplemental Content

Support Center